Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/60623
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Antimicrobial activity and spectrum of daptomycin: Results from the surveillance program in Australia and New Zealand (2008) |
Author: | Bell, J. Turnidge, J. Sader, H. Jones, R. |
Citation: | Pathology, 2010; 42(5):470-473 |
Publisher: | Taylor & Francis |
Issue Date: | 2010 |
ISSN: | 0031-3025 1465-3931 |
Statement of Responsibility: | Jan. M. Bell, John D. Turnidge, Helio S. Sader and Ronald N. Jones |
Abstract: | Aims: To assess invitro activity and spectrum of daptomycin, a new lipopeptide antimicrobial, against contemporary isolates of Gram positive pathogens in Australia and New Zealand in 2008. Methods: Gram positive isolates from patients with a range of bacterial infections served by seven Australian and three New Zealand laboratories were tested by broth microdilution and susceptibility results interpreted using current Clinical and Laboratory Standards Institute (CLSI) standards against daptomycin and a range of comparator agents including oxacillin, vancomycin and linezolid. Results: 872 Staphylococcus aureus (24.0% oxacillin resistant; Australia 28.4%, New Zealand 9.0%), 60 coagulase negative staphylococci (83.3% oxacillin resistant), 113 Enterococcus species (6.2% vancomycin non-susceptible), 40 viridans group Streptococcus species (7.5% penicillin resistant), and 158 β-haemolytic Streptococcus species were tested. Daptomycin was active against all 1243 strains, and no resistance or reduced susceptibility was detected, including among multi-resistant strains and those resistant to vancomycin. Conclusions: At the time of the introduction of daptomycin into clinical practice in Australia and New Zealand, this agent retains full activity and holds promise as an important therapeutic agent for treating serious Gram positive infections, including strains resistant to multiple other drug classes. |
Keywords: | Antibiotics microbiology bacteria daptomycin in vitro activity |
Rights: | © 2010 Royal College of Pathologists of Australasia |
DOI: | 10.3109/00313025.2010.493869 |
Published version: | http://dx.doi.org/10.3109/00313025.2010.493869 |
Appears in Collections: | Aurora harvest 5 Molecular and Biomedical Science publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.